+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hummingbird Diagnostics GmbH - Product Pipeline Analysis, 2021 Update

  • ID: 5367389
  • Company Profile
  • June 2021
  • 28 pages
  • GlobalData

FEATURED COMPANIES

  • NEO New Oncology AG
  • QIAGEN GmbH
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially derived from body fluid samples. It provides multilevel biomarker services and solutions. Hummingbird’s services comprise DNA and RNA extraction services, validation of biomarker candidates and quantitative analysis, microarray services and bioinformatic services, among others. Its products find applications in the treatment of cancer, chronic inflammatory diseases, cardiovascular diseases and infectious disease. The company caters to pharmaceutical, biotech industry and academic life science customers. Hummingbird is headquartered in Heidelberg, Baden-Wuerttemberg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Hummingbird Diagnostics GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • NEO New Oncology AG
  • QIAGEN GmbH
  • MORE
Hummingbird Diagnostics GmbH Company Overview
  • Hummingbird Diagnostics GmbH Company Snapshot
  • Hummingbird Diagnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
  • Hummingbird Diagnostics GmbH - Pipeline Analysis Overview
  • Hummingbird Diagnostics GmbH - Key Facts
  • Hummingbird Diagnostics GmbH - Major Products and Services
  • Hummingbird Diagnostics GmbH Pipeline Products by Development Stage
Hummingbird Diagnostics GmbH Pipeline Products Overview
  • Diagnostic Test - Acute Myocardial Infarction
  • Diagnostic Test - Acute Myocardial Infarction Product Overview
  • Diagnostic Test - Alzheimer's Disease
  • Diagnostic Test - Alzheimer's Disease Product Overview
  • Diagnostic Test - Breast Cancer
  • Diagnostic Test - Breast Cancer Product Overview
  • Diagnostic Test - Cancer Panel
  • Diagnostic Test - Cancer Panel Product Overview
  • Diagnostic Test - Heart Failure
  • Diagnostic Test - Heart Failure Product Overview
  • Diagnostic Test - IBD
  • Diagnostic Test - IBD Product Overview
  • Diagnostic Test - Melanoma
  • Diagnostic Test - Melanoma Product Overview
  • Diagnostic Test - Multiple Sclerosis
  • Diagnostic Test - Multiple Sclerosis Product Overview
  • Diagnostic Test - NSCLC
  • Diagnostic Test - NSCLC Product Overview
  • Diagnostic Test - Parkinson's Disease
  • Diagnostic Test - Parkinson's Disease Product Overview
Hummingbird Diagnostics GmbH - Key Competitors

Hummingbird Diagnostics GmbH - Key Employees

Hummingbird Diagnostics GmbH - Locations and Subsidiaries
  • Head Office
Recent Developments
  • Hummingbird Diagnostics GmbH, Recent Developments
  • Dec 14, 2015: Validation of Blood-based MiRNAs for Early Diagnosis of Lung Cancer
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Hummingbird Diagnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
  • Hummingbird Diagnostics GmbH Pipeline Products by Equipment Type
  • Hummingbird Diagnostics GmbH Pipeline Products by Indication
  • Hummingbird Diagnostics GmbH, Key Facts
  • Hummingbird Diagnostics GmbH, Major Products and Services
  • Hummingbird Diagnostics GmbH Number of Pipeline Products by Development Stage
  • Hummingbird Diagnostics GmbH Pipeline Products Summary by Development Stage
  • Diagnostic Test - Acute Myocardial Infarction - Product Status
  • Diagnostic Test - Acute Myocardial Infarction - Product Description
  • Diagnostic Test - Alzheimer's Disease - Product Status
  • Diagnostic Test - Alzheimer's Disease - Product Description
  • Diagnostic Test - Breast Cancer - Product Status
  • Diagnostic Test - Breast Cancer - Product Description
  • Diagnostic Test - Cancer Panel - Product Status
  • Diagnostic Test - Cancer Panel - Product Description
  • Diagnostic Test - Heart Failure - Product Status
  • Diagnostic Test - Heart Failure - Product Description
  • Diagnostic Test - IBD - Product Status
  • Diagnostic Test - IBD - Product Description
  • Diagnostic Test - Melanoma - Product Status
  • Diagnostic Test - Melanoma - Product Description
  • Diagnostic Test - Multiple Sclerosis - Product Status
  • Diagnostic Test - Multiple Sclerosis - Product Description
  • Diagnostic Test - NSCLC - Product Status
  • Diagnostic Test - NSCLC - Product Description
  • Diagnostic Test - Parkinson's Disease - Product Status
  • Diagnostic Test - Parkinson's Disease - Product Description
Hummingbird Diagnostics GmbH, Key Employees
  • Glossary
List of Figures
  • Hummingbird Diagnostics GmbH Pipeline Products by Equipment Type
  • Hummingbird Diagnostics GmbH Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • NEO New Oncology AG
  • QIAGEN GmbH
  • STRATIFYER Molecular Pathology GmbH
Note: Product cover images may vary from those shown
Adroll
adroll